Newsroom

The Pharmaceutical Printed Literature Association (PPLA) emphasizes how the FDA’s proposed digital-only format for Patient Medication Information (PMI) would worsen health disparities. Many low-income Americans lack access to digital resources, risking medication non-adherence and adverse effects. The bipartisan Patients’ Right to Know Their Medication Act (H.R. 1173) aims to preserve printed PMI for patient safety. Read More

The Pharmaceutical Printed Literature Association (PPLA) warns about health risks of shifting Patient Medication Information (PMI) to digital format due to expiring broadband access program. Over 100,000 annual deaths result from medication non-adherence, posing risks for 42 million Americans without broadband. PPLA supports the Patients’ Right to Know Their Medication Act (H.R. 1173) to maintain… Read More

A study by MLPS reveals proposed changes in patient medication information delivery could cost the EU up to €3.5 billion annually. The bipartisan Patients’ Right to Know Their Medication Act aims to protect access to printed PMI and has 14 bipartisan cosponsors. The Pharmaceutical Printed Literature Association advocates for patient safety and accessibility. Read More

The Pharmaceutical Printed Literature Association (PPLA) is advocating for the Patients’ Right to Know Their Medication Act (H.R. 1173), with strong bipartisan Congressional support. The bill aims to ensure patients have access to printed Patient Medication Information (PMI) with FDA-approved content, resisting a proposed FDA rule to digitize PMI, which could hinder access for rural… Read More

The Pharmaceutical Printed Literature Association (PPLA) opposes the FDA’s rule lowering access to printed Patient Medication Information (PMI) due to its potential negative impact. The rule would shift PMI to digital format, raising concerns about access and cost. The PPLA advocates for the bipartisan Patients’ Right to Know Their Medication Act to standardize PMI based… Read More